November is Medical Marijuana Research Month!
Medical Marijuana Research Month is a chance for customers at dispensaries and marijuana retail stores nationwide to make a donation during the month of November to support MAPS’ research on whole …
Research
HHS Denies Request from 30 Members of Congress to End Obstructive Review Process
On September 22, 2014, U.S. Department of Health and Human Services Secretary Sylvia M. Burwell formally rejected a request from 30 members of Congress requesting that HHS end the obstructive Public Health …
LSD Annual Report Submitted to FDA
On May 16, 2014, the annual report for LSD-assisted psychotherapy for anxiety associated with advanced-stage illness was submitted to the U.S. Food and Drug Administration. The required report provides …
LSD Study Breaks 40 Years of Research Taboo
On March 4, 2014, the results of the first study of the therapeutic use of lysergic acid diethylamide (LSD) in humans in over 40 years were published online in the peer-reviewed Journal of Nervous and …
New Zealand: 14th and Final Subject Enrolled
On April 27, 2014, the 14th and final subject was enrolled in our nearly completed New Zealand observational study of ibogaine assisted treatment for opioid dependence. Since July 2012, Principal Investigator …
Switzerland: Results Published in Journal of Nervous Mental Disease
On March 4, 2014, the results of our completed study of the therapeutic use of lysergic acid diethylamide (LSD) to treat anxiety associated with advanced-stage illness were published online in the peer-reviewed …
Switzerland: Paper Accepted for Publication in Journal of Nervous and Mental Disease
On December 23, 2013, the results of our completed Swiss study of LSD-assisted psychotherapy for anxiety associated with life-threatening illness were accepted for publication in the peer-reviewed Journal …
Boulder: Fourth Subject Enrolled and Treated; Fifth Subject Enrolled
On December 6, 2013, the fourth subject began treatment in our ongoing Boulder, Colorado, study of MDMA-assisted psychotherapy for 17 subjects with chronic, treatment-resistant PTSD. This subject was enrolled …
U.S. Veterans: 14th Subject Treated
Note: We are now subtracting dropouts from the total number of subjects treated to more accurately reflect study progress. On November 8, 2013, the 14th subject began treatment in our ongoing study of …
U.S. Veterans: 15th Subject Receives Treatment; DEA Approves Amended Protocol
On October 5, 2013, the 15th subject was treated in our ongoing study of MDMA-assisted psychotherapy for U.S. veterans, firefighters, and police officers with service-related PTSD. On October 3, the U.S. …
Final Report Submitted to SwissMedic
On September 17, 2013, the Final Report for our completed Swiss study of LSD-assisted psychotherapy for anxiety associated with advanced stage illness was submitted to Swissmedic. The report contains information …
U.S. Veterans: 14th Subject Completes Experimental Sessions; IRB Approves Amended Protocol
On September 12, 2013, the 15th subject was enrolled in our ongoing study of MDMA-assisted psychotherapy for 24 U.S. veterans, firefighters, and police officers with service-related PTSD. The 14th subject …